Elevation Oncology, Inc.

ELEV · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$44-$46-$95-$32
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0-$2
Stock-Based Comp.$4$3$3$2
Change in WC$4-$14$6$0
Other Non-Cash-$0-$0$0$2
Operating Cash Flow-$36-$56-$85-$30
Investing Activities
PP&E Inv.$0$0-$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$70-$43-$112$0
Inv. Sales/Matur.$61$54$68$0
Other Inv. Act.$0$0-$0$0
Investing Cash Flow-$8$12-$44$0
Financing Activities
Debt Repay.$0$0$30$0
Stock Issued$44$47$0$97
Stock Repurch.-$0-$0-$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1$1-$0-$0
Financing Cash Flow$45$48$30$97
Forex Effect$0$0$0$0
Net Chg. in Cash$0$3-$100$67
Supplemental Information
Beg. Cash$49$46$146$79
End Cash$49$49$46$146
Free Cash Flow-$36-$56-$86-$30